The new therapeutic domain is chimera peptides. These designed molecules merge sections derived from different peptide origins, allowing the development of distinct pharmacological characteristics. The method provides https://chimerapeptides912353.jaiblogs.com/70685172/chimera-peptides-a-novel-therapeutic-frontier